Allergic Rhinitis-Asthma Syndrome
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Inclusion criteria: 1. Patients who meet the diagnostic criteria of both traditional Chinese and Western medicine for CARAS and are currently in the remission phase; 2.No restriction on gender, aged 18 to 75 years; 3.Voluntarily participate in this clinical trial, voluntarily sign the informed consent form, and are willing to follow the research protocol.
Exclusion criteria
Exclusion criteria: 1. Not meeting the eligibility criteria requirements; 2. Patients suffering from severe cardiovascular, cerebrovascular, hepatic, renal, or hematopoietic system diseases, or patients with severe primary diseases and mental illness; 3. Patients with a history of skin allergies or allergies to known components of the drug; 4. Patients with incomplete data affecting the assessment of efficacy or safety; 5. Patients with conditions unsuitable for application or other severe complications; 6. Patients unwilling to continue clinical observation during the application period or unable to undergo long-term follow-up; 7. Patients currently participating in other clinical trials of drugs.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The proportion of CARAS patients experiencing acute exacerbations of rhinitis or asthma within 1 year.; | — |
Secondary
| Measure | Time frame |
|---|---|
| TCM Syndrome Score Improvement Rate; | — |
Countries
China
Contacts
Zhejiang Provincial Hospital of Traditional Chinese Medicine (Affiliated First Hospital of Zhejiang University of Traditional Chinese Medicine)